Article Information
History
- May 18, 2024.
Article Versions
- You are currently viewing Version 1 of this article (May 18, 2024 - 10:06).
- Version 2 (July 3, 2024 - 11:26).
- Version 3 (July 15, 2024 - 13:37).
- Version 4 (August 13, 2024 - 14:07).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sachin J Shah, MD, MPH1,2,*,
- Jay M. Iyer3,
- Leila Agha, PhD4,
- Yuchiao Chang, PhD1,
- Jeffrey M. Ashburner, PhD, MPH1,
- Steven J. Atlas, MD, MPH1,
- David D. McManus, MD, ScM5,
- Patrick T. Ellinor, MD, PhD6,
- Steven A. Lubitz, MD, MPH6 and
- Daniel E. Singer, MD1
- 1Division of General Internal Medicine at Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- 2Center for Aging and Serious Illness, Massachusetts General Hospital
- 3Departments of Molecular and Cellular Biology and Statistics, Harvard University, Cambridge, MA, USA
- 4Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
- 5Department of Medicine, UMass Chan Medical School, Worcester, MA, USA
- 6Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- ↵*Contact Sachin J Shah, MD, MPH, 100 Cambridge St, Suite 1600, Boston, MA 02114 sshah{at}mgh.harvard.edu 617-977-4871
Posted May 18, 2024.
Identifying a Heterogeneous Effect of Atrial Fibrillation Screening in Older Adults: A Secondary Analysis of the VITAL-AF Trial
